Sign In
Buy NLTBF
Nolato Ab (publ) Earnings Calls
| Release date | Jul 17, 2026 |
| EPS estimate | $0.0692 |
| EPS actual | $0.0654 |
| EPS Surprise | -5.59% |
| Revenue estimate | 251.882M |
| Revenue actual | 254.553M |
| Revenue Surprise | 1.06% |
| Release date | May 06, 2026 |
| EPS estimate | $0.0741 |
| EPS actual | $0.0705 |
| EPS Surprise | -4.83% |
| Revenue estimate | 248.819M |
| Revenue actual | 247.956M |
| Revenue Surprise | -0.347% |
| Release date | Feb 05, 2026 |
| EPS estimate | $0.0779 |
| EPS actual | $0.0606 |
| EPS Surprise | -22.22% |
| Revenue estimate | 246.696M |
| Revenue actual | 245.83M |
| Revenue Surprise | -0.351% |
| Release date | Oct 29, 2025 |
| EPS estimate | $0.0830 |
| EPS actual | $0.0852 |
| EPS Surprise | 2.58% |
| Revenue estimate | 243.322M |
| Revenue actual | 249.337M |
| Revenue Surprise | 2.47% |
Last 4 Quarters for Nolato Ab (publ)
Below you can see how NLTBF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Oct 29, 2025 |
| Price on release | $6.48 |
| EPS estimate | $0.0830 |
| EPS actual | $0.0852 |
| EPS surprise | 2.58% |
| Date | Price |
|---|---|
| Oct 23, 2025 | $6.48 |
| Oct 24, 2025 | $6.00 |
| Oct 27, 2025 | $6.48 |
| Oct 28, 2025 | $6.48 |
| Oct 29, 2025 | $6.48 |
| Oct 30, 2025 | $6.48 |
| Oct 31, 2025 | $6.00 |
| Nov 03, 2025 | $6.48 |
| Nov 04, 2025 | $6.48 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
| Release date | Feb 05, 2026 |
| Price on release | $6.00 |
| EPS estimate | $0.0779 |
| EPS actual | $0.0606 |
| EPS surprise | -22.22% |
| Date | Price |
|---|---|
| Jan 30, 2026 | $6.53 |
| Feb 02, 2026 | $6.53 |
| Feb 03, 2026 | $6.53 |
| Feb 04, 2026 | $6.53 |
| Feb 05, 2026 | $6.00 |
| Feb 06, 2026 | $6.53 |
| Feb 09, 2026 | $6.53 |
| Feb 10, 2026 | $6.53 |
| Feb 11, 2026 | $6.53 |
| 4 days before | -8.12% |
| 4 days after | 8.83% |
| On release day | 8.83% |
| Change in period | 0% |
| Release date | May 06, 2026 |
| Price on release | $6.00 |
| EPS estimate | $0.0741 |
| EPS actual | $0.0705 |
| EPS surprise | -4.83% |
| Date | Price |
|---|---|
| Apr 30, 2026 | $6.53 |
| May 01, 2026 | $6.53 |
| May 04, 2026 | $6.53 |
| May 05, 2026 | $6.53 |
| May 06, 2026 | $6.00 |
| May 07, 2026 | $6.53 |
| May 08, 2026 | $6.00 |
| May 11, 2026 | $6.53 |
| May 12, 2026 | $6.53 |
| 4 days before | -8.12% |
| 4 days after | 8.83% |
| On release day | 8.83% |
| Change in period | 0% |
| Release date | Jul 17, 2026 |
| Price on release | $4.92 |
| EPS estimate | $0.0692 |
| EPS actual | $0.0654 |
| EPS surprise | -5.59% |
| Date | Price |
|---|---|
| Jul 13, 2026 | $4.92 |
| Jul 14, 2026 | $4.92 |
| Jul 15, 2026 | $4.92 |
| Jul 16, 2026 | $4.92 |
| Jul 17, 2026 | $4.92 |
| Jul 20, 2026 | $4.92 |
| Jul 21, 2026 | $4.92 |
| Jul 22, 2026 | $4.92 |
| Jul 23, 2026 | $4.92 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
Nolato Ab (publ) Earnings Call Transcript Summary of Q2 2026
Nolato reported Q2 2026 sales of SEK 2,454 million, currency-adjusted growth of ~4%, with Medical Solutions and Engineered Solutions both growing (Medical stronger). Group EBITA was SEK 247 million (10.1% margin), down from 11.6% YoY, mainly due to higher raw material (oil-driven) costs (~SEK 20m impact) and startup/ramp-up costs for new medical programs (~SEK 10m). Cash flow was strong (SEK 287m in the quarter; cash flow after investments SEK 154m H1), net financial liabilities (ex. pensions & leases) were SEK 1,055m or 0.7x EBITA, leaving the group with financial flexibility for an intensified M&A agenda. Net investments decreased (Q2 capex SEK 133m; full-year capex guidance SEK 600–650m) as most Hungarian expansion capex has been paid. Key operational notes: Hungarian site started commercial GLP-1 production late in Q2 with gradual ramp to full volumes by ~2029 (steady ramp rather than lumpy), materials business delivered strong growth (19% organic) and is capital-light, consumer electronics showed resilience, while hygiene and automotive were weaker. Management expects about two-thirds of the raw-material cost impact was absorbed in Q2 with remaining effects flowing into early Q3, and margin pressure from project ramp-ups to ease gradually as volumes increase.
